Clinical presentation and physical examination
Disease onset is sudden. The child may experience severe chills, followed by a rapidly escalating intoxication syndrome. Unlike many other respiratory infections, in influenza, toxicosis comes to the forefront. High fever is registered in the patient, accompanied by severe headache, as well as muscle aches (myalgia) and joint aches (arthralgia).
During physical examination, the pediatrician notes the patient's characteristic appearance: the face becomes hyperemic, and the vessels of the sclera and conjunctiva are injected. Pharyngoscopy reveals marked hyperemia of the oropharyngeal mucosa with a specific cyanotic tint. Additionally, nosebleeds (epistaxis) may occur.
Catarrhal syndrome is extremely mild: rhinitis is insignificant, and lymph node enlargement (lymphadenopathy) is completely uncharacteristic of this infection. The cough is usually dry, which is pathogenetically conditioned by the development of concomitant tracheitis.
Comprehensive prevention
Infection prevention is comprehensive and strictly divided into three main areas:
- Sanitary and epidemiological measures. Interrupting transmission routes through early isolation of the sick child plays a key role, protecting the family and children's collective. In the infection focus, a strict sanitary regime must be maintained: regular wet cleaning of premises and disinfection of tableware by boiling. During an epidemic, organizational restrictions aimed at minimizing population crowding are additionally introduced.
- Nonspecific prevention. Aimed at the general enhancement of baseline body resistance. This includes various hardening methods, as well as the use of nonspecific immunotropic drugs.
- Specific prevention (vaccination). This is the most reliable method of protection. The target audience for vaccination is children starting from 6 months of age. Vaccination is carried out annually, strictly before the start of the epidemic season (optimally 1–2 months before the expected rise in morbidity, allowing sufficient time for full immunity to develop).
Various preparations are used for immunization. Among them are inactivated vaccines with the addition of a special immunoadjuvant (azoximer bromide) — the Grippol product line (Grippol, MonoGrippol plus, MonoGrippol Neo). Other inactivated vaccines (split vaccines and subunit preparations) are also widely used: Vaxigrip, Influvac, Begrivac, Fluarix.
Prognosis and life-threatening conditions
In the overwhelming majority of clinical cases, the disease has a favorable overall prognosis and ends in complete recovery of the patient.
However, influenza poses a serious danger with the development of severe forms of the infection. The risk of a fatal outcome is directly associated with the occurrence of critical complications. The most formidable life-threatening conditions include:
- Toxic encephalopathy accompanied by damage to brain structures.
- Acute pulmonary edema.
- Acute stenosing laryngotracheitis (croup syndrome), particularly its severe manifestations (grade III–IV stenosis).
For quick memorization of the clinical profile of influenza, use the mnemonic rule «GIANT»: Generalized hyperemia of the face, Intoxication (predominant), Gorlo (throat) with a cyanotic tint, Arthralgia, No lymphadenopathy, Tracheitis (provoking dry cough).
Class and exam questions
Which syndrome predominates in the typical course of influenza in a child?
Severe systemic toxicosis always comes to the forefront, accompanied by high fever, chills, myalgia, and headache. At the same time, local catarrhal manifestations (such as a runny nose) are mild.
What is the optimal timing for vaccinating children against influenza?
Specific prevention should be carried out annually, strictly before the start of the epidemic season. The ideal time is 1–2 months before the expected rise in morbidity, allowing the immune system time to produce protective antibodies.
Starting from what age is vaccination approved and what preparations are used?
Children can be vaccinated starting from 6 months of age. Various inactivated vaccines are used for this purpose: both preparations with an immunoadjuvant (Grippol line) and split or subunit vaccines (Vaxigrip, Influvac, and others).
Which complications of influenza can lead to a fatal outcome?
Despite the generally favorable prognosis, severe forms can be complicated by life-threatening conditions: toxic encephalopathy, acute pulmonary edema, and grade III–IV acute stenosing laryngotracheitis (croup syndrome).
What else to study on this topic
- Clinical differential diagnosis of influenza and other ARVI
- Mechanisms of development and management of toxic encephalopathy
- Pathogenesis of acute stenosing laryngotracheitis (croup)
- Regimens of nonspecific immunotropic therapy in pediatrics
- Features of adjuvant use in modern pediatric vaccines
Master the entire topic in the Pediatrics course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Influenza in Children» and 3,738 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 71 video lessons on the subject
Other topics from the section «Chapter 12. Infectious and parasitic diseases»
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.